In particular cases, concurrent administration of ciprofloxacin and glyburide can intensify the action of glyburide (hypoglycemia).

In particular cases, concurrent administration of ciprofloxacin and glyburide can intensify the action of glyburide (hypoglycemia).

Examples of insulin secretion stimulating drugs are glyburide and glimepiride.

Concomitant administration of colesevelam and glyburide tablets (micronized resulted in reductions in glyburide AUC and Cmax of 32% and 47%, respectively.

Weight Gain: Glimepiride, like all sulfonylureas, can cause weight gain.

Prefered medicaments are glibenclamide and 3-indolylacetic acid derivates, such as indometacin or acemetacin.

When used together with an antidiabetic agent such as insulin, glibenclamide, acarbose or rosiglitazone, it exerts an enhanced antidiabetic effect.

No significant changes were observed in the total plasma concentration of glibenclamide.

Weight Gain: Glimepiride, like all sulfonylureas, can cause weight gain.

Weight Gain: Glimepiride, like all sulfonylureas, can cause weight gain.

Glyburide—In a single-dose interaction study in type 2 diabetes patients, co-administration of metformin and glyburide did not result in any changes in either metformin pharmacokinetics or pharmacodynamics.

Glyburide – In a single-dose interaction study in type 2 diabetes patients, co-administration of Metformin and glyburide did not result in any changes in either Metformin pharmacokinetics or pharmacodynamics.

The solid dispersion containing glibenclamide 2-60% and disperse medium 98-40% by the ratio of weight.

The NCCa-ATP channel is regulated by a sulfonylurea receptor and is inhibited by sulfonylurea compounds glibenclamide and tolbutamide.

Therefore, glibenclamide should be taken at least 4 hours before colesevelam.